What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Surgery, Hepatocellular carcinoma, Internal medicine, Liver transplantation and Transplantation are his primary areas of study.
His research in Surgery intersects with topics in Diabetes mellitus, Liver function, Liver function tests and Ischemia.
His Hepatocellular carcinoma study focuses on Liver cancer in particular.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Oncology.
His Liver transplantation study combines topics in areas such as Fulminant and Gerontology.
His work deals with themes such as Incidence, Chemotherapy, Complication, Prothrombin time and Risk factor, which intersect with Transplantation.
His most cited work include:
- Sorafenib in Advanced Hepatocellular Carcinoma (7596 citations)
- Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma (1322 citations)
- Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis (1170 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Hepatocellular carcinoma, Surgery, Liver transplantation and Gastroenterology.
His studies in Internal medicine integrate themes in fields like Oncology and Pathology.
His biological study deals with issues like Carcinoma, which deal with fields such as Survival analysis.
As part of his studies on Surgery, Myron Schwartz often connects relevant subjects like Liver function.
He interconnects Liver disease, Immunosuppression and Prothrombin time in the investigation of issues within Liver transplantation.
His Gastroenterology study integrates concerns from other disciplines, such as Hepatitis B, Immunology, Tacrolimus and Hepatitis C virus.
He most often published in these fields:
- Internal medicine (43.91%)
- Hepatocellular carcinoma (35.40%)
- Surgery (35.59%)
What were the highlights of his more recent work (between 2014-2021)?
- Hepatocellular carcinoma (35.40%)
- Internal medicine (43.91%)
- Gastroenterology (31.72%)
In recent papers he was focusing on the following fields of study:
Myron Schwartz mostly deals with Hepatocellular carcinoma, Internal medicine, Gastroenterology, Radiology and Oncology.
His Hepatocellular carcinoma research incorporates elements of Carcinoma, Pathology, Liver transplantation and Surgery.
His Liver transplantation study is related to the wider topic of Transplantation.
Myron Schwartz combines Internal medicine and In patient in his studies.
The Gastroenterology study combines topics in areas such as Proportional hazards model and Hazard ratio.
His work carried out in the field of Liver cancer brings together such families of science as Stage and Hepatitis C.
Between 2014 and 2021, his most popular works were:
- Global patterns of hepatocellular carcinoma management from diagnosis to death: The BRIDGE Study (358 citations)
- Recurrence of Hepatocellular Cancer After Resection: Patterns, Treatments, and Prognosis (207 citations)
- The role of hepatic resection in the treatment of hepatocellular cancer (163 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Myron Schwartz spends much of his time researching Hepatocellular carcinoma, Internal medicine, Gastroenterology, Carcinoma and Liver transplantation.
His work on Liver cancer as part of general Hepatocellular carcinoma study is frequently linked to Response Evaluation Criteria in Solid Tumors, therefore connecting diverse disciplines of science.
The various areas that Myron Schwartz examines in his Internal medicine study include Surgery and Oncology.
His Gastroenterology research integrates issues from Etiology, Proportional hazards model and Hazard ratio, Confidence interval.
His research integrates issues of Cancer, Incidence, Embolization and Gene expression profiling in his study of Carcinoma.
The concepts of his Liver transplantation study are interwoven with issues in Tumor size and Overall survival.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
